Imerys (NK) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
9 Jul, 2026Executive summary
2024 revenue reached €3,605 million, up 1% organically, with Q4 marking the third consecutive quarter of organic growth (+3.5% year-over-year).
Adjusted EBITDA rose 11.4% like-for-like to €675 million, with margin up 110 bps to 18.7%, in line with guidance.
Net income from continuing operations increased 8.2% to €262 million; Group share net income was impacted by a non-cash translation reserve loss from asset disposal.
Free operating cash flow before strategic capex was €209 million; reported at €136 million after strategic investments.
Proposed dividend of €1.45 per share, a 7.4% increase, maintaining a 47% payout ratio.
Financial highlights
Adjusted EBITDA margin improved to 18.7% (+110 bps year-over-year); Q4 adjusted EBITDA up 13.9% like-for-like.
Q4 2024 revenue grew 3.5% organically, driven by positive volumes (+2.1%) and price increases (+1.4%).
FY 2024 organic revenue growth was 0.9%, with volumes up 1.1% and prices stabilizing at -0.3%.
Net financial debt to adjusted EBITDA was 1.9x at year-end 2024; investment grade ratings confirmed.
Net income, Group share, was -€95 million due to a non-cash loss from translation reserve recycling after asset disposal.
Outlook and guidance
Expects further volume growth in 2025 despite ongoing economic uncertainty, with focus on cost control, cash generation, and leveraging recent capacity investments.
Anticipates positive pricing in 2025, with mechanical uplift from Q4 2024 price increases.
Recovery expected in construction and consumer goods, especially in the U.S. and Europe as interest rates drop; automotive recovery may take longer.
No formal EBITDA guidance provided early in the year due to market uncertainties.
2025 capex (excluding lithium) expected below €280 million.
Latest events from Imerys
- All resolutions passed, with strong 2024 results, higher dividend, and strategic progress.NK
AGM 20258 Jul 2026 - All resolutions passed, with stable financials, new board members, and key strategic initiatives advanced.NK
AGM 20268 Jul 2026 - H1 2024 adjusted EBITDA rose 11% to €384 million, margin 20%, with strong net income growth.NK
H1 20248 Jul 2026 - Q1 2026 saw modest growth and margin gains, offset by FX and restructuring impacts.NK
Q1 202629 Apr 2026 - Stable 2025 results, major goodwill impairment, and cost savings plus lithium investment ahead.NK
Q4 202520 Feb 2026 - Nine-month EBITDA margin rose to 19.2% as full-year guidance is confirmed.NK
Q3 202417 Jan 2026 - Organic growth and sustainability progress offset margin pressure from joint venture declines.NK
Q1 202524 Dec 2025 - Stable H1 2025 sales and EBITDA, but net income fell; full-year EBITDA guidance reaffirmed.NK
Q2 202516 Nov 2025 - Revenue down 0.7% YTD; cost controls and strategic growth moves support profitability.NK
Q3 20251 Nov 2025